An analysis of data from more than 900 patients who underwent surgery for renal cell carcinoma showed that statin use was associated with a lower risk of cancer progression and death. Nearly four years after surgery, 10% of statin users died of kidney cancer compared with 17% of nonusers, researchers found. The findings were reported at the annual meeting of the American Urological Association.
Statins may lower mortality risk in kidney cancer patients
SmartBrief Job Listings for Health Care
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|
|Director Account Management||
Samaritan Health Services
|Hospital Medical Device Sales||
Linda Hertz Group